96

Contamination Control Compass
Edition #08/2024

Informative Articles
Latest Changes in Complete Pyrogen and Bacterial Endotoxin Testing Requirements

Photo animal testing: iStock.com/unoL | Photo horseshoe crab: pixabay.com/Pexels

In the pharmaceutical industry, the safety of products is paramount, particularly when it comes to preventing adverse reactions in patients. One critical aspect of safety testing is pyrogen detection. Complete pyrogen testing is essential for ensuring that pharmaceutical products, especially those administered intravenously, are free from these harmful substances.

Find out more about what pyrogens are, how they can be detected and what regulatory changes pharmaceutical companies are now facing.

Join us at the PDA Pharmaceutical Microbiology Conference 2024, where we'll bridge science and compliance!


07-09 OCTOBER | WASHINGTON, DC. | BOOTH #405

Product Highlights
Coming Soon: Products for AAV Vector Titer Determination

Adeno-associated virus (AAV) vectors are among the most prominent viral vectors for in vivo gene therapy. Viral genome titer is a critical quality attribute in AAV characterization for safe and efficacious gene therapy products. Specificity of AAV vectors as well as the concentration of the vector titer must be determined throughout the production process and for final release testing.


The MiQuant® AAV kits have been developed for the determination of AAV vector titer. Different kit versions enable the specific detection of AAV ITR 2/6 (including ITR 1, 3 & 7) or ITR 5.

Beta Testers Wanted!

Minerva Biolabs is looking for testers for the new MiQuant® AAV.

Send a mail to miquant@minerva-biolabs.com for more information.

Here's to clean cultures and reliable results!


Warm regards,

Your MB Team

Do you need technical support or have questions regarding our products? Please contact support@minerva-biolabs.com. Any feedback or suggestions? Write an email to newsletter@minerva-biolabs.com.